GCP, or Good Clinical Practice, is an international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials involving human subjects. It provides assurance that the rights, safety, and well-being of trial participants are protected, and that clinical trial data are credible.
GCP guidelines were developed by the International Conference on Harmonisation (ICH) and are used by regulatory authorities worldwide. Adherence to GCP principles ensures that clinical research is conducted to the highest standards, promoting public confidence in clinical research and facilitating the acceptance of clinical data by regulatory authorities.
GCP is crucial in clinical research as it establishes a unified standard for conducting trials across different countries and institutions. This standardization ensures that data from various studies can be compared and combined, enhancing the overall quality and reliability of clinical research outcomes.
Additionally, adherence to GCP principles protects the rights, safety, and well-being of trial participants, which is fundamental to ethical research practices. It also increases the credibility of study results, making them more likely to be accepted by regulatory authorities for drug approvals and treatment recommendations.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant